Scientists used advanced data analysis and machine learning to identify the viral proteins that may trigger autoimmune disorders such as type 1 diabetes and rheumatoid arthritis.

Six years before the start of the COVID-19 pandemic, an Ebola outbreak in West Africa had people fearing the possibility of a ...

Lenacapavir is the only approved HIV capsid inhibitor. Teropavimab (GS-5423) is derived from a bnAb called 3BNC117 that targets the CD4 binding site, which the virus uses to enter cells. Zinlirvimab ...

Just like malicious apps on your smartphone, malicious browser extensions can put your devices and the sensitive data stored in your browser at serious risk. The problem with malicious browser ...

AI-assisted adeno-associated virus (AAV) capsid engineering has transformative potential in terms of accelerating and optimizing the development of gene therapies. That’s the view of Fangzhi Tan ...

The 3.0 Å resolution crystal structure of Pariacoto virus (PaV) reveals extensive interactions between portions of the viral RNA genome and the icosahedral capsid ... in both shape and ...

As virus experts, we’re committed to research that uncovers pandemic threats and helps protect people from them. But we are concerned about how some scientists are experimenting with viruses in ...

The T-1000 in Terminator 2 could change shape at will, morph its hands into blades or turn parts of its body into a fluid to move through metal bars. “I saw this movie when I was a child—it ...

This involves the HIV-1 protease (a viral enzyme), that cuts up Gag into six smaller proteins including the capsid protein and the matrix protein. This causes a huge structural rearrangement of the ...

For many years, scientists have explored the structural changes of the virus capsid which encases the genome. In contrast, much less is known about the virus matrix—the outer protein shell ...

John Etnyre receives funding from the National Science Foundation and the Elaine M. Hubbard Distinguished Faculty Award When you look at your surrounding environment, it might seem like you’re ...

Taysha Gene Therapies (Nasdaq: TSHA) is a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based ... commercially proven AAV9 capsid in an effort to rapidly ...